These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats. Skrede S; Fernø J; Vázquez MJ; Fjær S; Pavlin T; Lunder N; Vidal-Puig A; Diéguez C; Berge RK; López M; Steen VM Int J Neuropsychopharmacol; 2012 Mar; 15(2):163-79. PubMed ID: 21854679 [TBL] [Abstract][Full Text] [Related]
3. Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat. Kirk SL; Neill JC; Jones DN; Reynolds GP Eur J Pharmacol; 2004 Nov; 505(1-3):253-4. PubMed ID: 15556160 [TBL] [Abstract][Full Text] [Related]
4. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone. Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897 [TBL] [Abstract][Full Text] [Related]
5. Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats. Kalinichev M; Rourke C; Daniels AJ; Grizzle MK; Britt CS; Ignar DM; Jones DN Psychopharmacology (Berl); 2005 Oct; 182(2):220-31. PubMed ID: 16001110 [TBL] [Abstract][Full Text] [Related]
6. Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats. Fell MJ; Neill JC; Anjum N; Peltola LM; Marshall KM J Psychopharmacol; 2008 Mar; 22(2):182-6. PubMed ID: 18308803 [TBL] [Abstract][Full Text] [Related]
7. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model. Deng C; Lian J; Pai N; Huang XF J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490 [TBL] [Abstract][Full Text] [Related]
8. Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats. Hartfield AW; Moore NA; Clifton PG Neuropsychopharmacology; 2006 Sep; 31(9):1938-45. PubMed ID: 16292324 [TBL] [Abstract][Full Text] [Related]
9. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111 [TBL] [Abstract][Full Text] [Related]
10. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study. McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384 [TBL] [Abstract][Full Text] [Related]
11. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression. Han M; Deng C; Burne TH; Newell KA; Huang XF Psychoneuroendocrinology; 2008 Jun; 33(5):569-80. PubMed ID: 18358632 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of atypical antipsychotic drugs against MPP(+)-induced oxidative stress in PC12 cells. Park SW; Lee CH; Lee JG; Kim LW; Shin BS; Lee BJ; Kim YH Neurosci Res; 2011 Apr; 69(4):283-90. PubMed ID: 21238512 [TBL] [Abstract][Full Text] [Related]
13. Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats. Fell MJ; Gibson R; McDermott E; Sisodia G; Marshall KM; Neill JC Behav Brain Res; 2005 May; 160(2):338-43. PubMed ID: 15863230 [TBL] [Abstract][Full Text] [Related]
14. A role of neuropeptide CART in hyperphagia and weight gain induced by olanzapine treatment in rats. Nakhate KT; Subhedar NK; Kokare DM Brain Res; 2018 Sep; 1695():45-52. PubMed ID: 29775565 [TBL] [Abstract][Full Text] [Related]
15. Comparative effects of olanzapine and ziprasidone on hypophagia induced by enhanced histamine neurotransmission in the rat. Davoodi N; Kalinichev M; Clifton PG Behav Pharmacol; 2008 Mar; 19(2):121-8. PubMed ID: 18332676 [TBL] [Abstract][Full Text] [Related]
16. The effect of ziprasidone on body weight and energy expenditure in female rats. Park S; Kim MS; Namkoong C; Park MH; Hong JP Metabolism; 2012 Jun; 61(6):787-93. PubMed ID: 22209671 [TBL] [Abstract][Full Text] [Related]
17. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744 [TBL] [Abstract][Full Text] [Related]
18. Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine. Kalinichev M; Rourke C; Jones DN Behav Pharmacol; 2006 May; 17(3):289-92. PubMed ID: 16572006 [TBL] [Abstract][Full Text] [Related]
19. Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats. De Santis M; Pan B; Lian J; Huang XF; Deng C Pharmacol Biochem Behav; 2014 Sep; 124():167-73. PubMed ID: 24933333 [TBL] [Abstract][Full Text] [Related]
20. Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats. He M; Zhang Q; Deng C; Wang H; Lian J; Huang XF Psychoneuroendocrinology; 2014 Apr; 42():153-64. PubMed ID: 24636512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]